U.S. World Business Lifestyle
Today: May 05, 2025
Today: May 05, 2025

Technology

Business|Economy|Europe|Technology

Safran offers remedies to win EU approval for Collins deal

French engine and aircraft equipment maker Safran has offered remedies in an attempt to secure EU antitrust approval for its $1.8 billion bid for Collins

Safran offers remedies to win EU approval for Collins deal
Education|Science|Technology|US

'Follow your dreams': Astronaut Peggy Whitson inspires next generation ahead Axiom Mission 4

'Follow your dreams': Astronaut Peggy Whitson inspires next generation ahead Axiom Mission 4

'Follow your dreams': Astronaut Peggy Whitson inspires next generation ahead Axiom Mission 4
Business|Economy|Europe|Technology

Stellantis invests $41 million in Italy to make EV engine parts

Automaker Stellantis is investing 38 million euros ($41 million) in its Verrone plant in Northern Italy to manufacture parts for electric engines for its upcoming small-size models,

Stellantis invests $41 million in Italy to make EV engine parts
Asia|Business|Technology

BYD unveils new super-charging EV tech, to build charging network in China

BYD on Monday unveiled a new platform for electric vehicles (EVs) that it said could charge EVs as quickly as it takes to pump gas and announced for the first time that it would

BYD unveils new super-charging EV tech, to build charging network in China
Business|Economy|Science|Technology

Nvidia CEO to defend AI dominance as competition intensifies

By Stephen Nellis and Max A.

Nvidia CEO to defend AI dominance as competition intensifies
Business|Economy|Finance|Technology|US

DuPont insider Jon Kemp to lead electronics unit post spinoff

Chemicals firm DuPont De Nemours said on Monday insider Jon Kemp will take over as CEO of its independent electronics unit following the planned spinoff of the business.

DuPont insider Jon Kemp to lead electronics unit post spinoff
Business|Economy|Health|Science|Technology

AstraZeneca boosts cancer therapies push with $1 billion EsoBiotec buy

Drugmaker AstraZeneca has agreed to buy Belgium-based biotechnology firm EsoBiotec for up to $1 billion, it said on Monday, seeking to accelerate the development of its

AstraZeneca boosts cancer therapies push with $1 billion EsoBiotec buy
Technology

Google Fast Facts

Google Fast Facts

Business|Political|Technology|US

Meta Fast Facts

Meta Fast Facts